These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30145862)

  • 1. Effects of Three Thiazolidinediones on Metabolic Regulation and Cold-Induced Thermogenesis.
    Sohn JH; Kim JI; Jeon YG; Park J; Kim JB
    Mol Cells; 2018 Oct; 41(10):900-908. PubMed ID: 30145862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown Adipose Tissue PPARγ Is Required for the Insulin-Sensitizing Action of Thiazolidinediones.
    Shibata Y; Eguchi J; Wada J
    Acta Med Okayama; 2023 Jun; 77(3):243-254. PubMed ID: 37357625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold acclimation and pioglitazone combined increase thermogenic capacity of brown and white adipose tissues but this does not translate into higher energy expenditure in mice.
    Valdivia LFG; Castro É; Eichler RADS; Moreno MF; de Sousa É; Jardim GFR; Peixoto ÁS; Moraes MN; Castrucci AML; Nedergaard J; Petrovic N; Festuccia WT; Reckziegel P
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E358-E373. PubMed ID: 36856189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice.
    Wu D; Eeda V; Undi RB; Mann S; Stout M; Lim HY; Wang W
    Mol Metab; 2021 Dec; 54():101363. PubMed ID: 34710641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice.
    Kim G; Lee YH; Yun MR; Lee JY; Shin EG; Lee BW; Kang ES; Cha BS
    Int J Obes (Lond); 2018 Mar; 42(3):542-551. PubMed ID: 28895584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.
    Coelho MS; de Lima CL; Royer C; Silva JB; Oliveira FC; Christ CG; Pereira SA; Bao SN; Lima MC; Pitta MG; Pitta IR; Neves FA; Amato AA
    PLoS One; 2016; 11(5):e0154310. PubMed ID: 27138164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ agonist rosiglitazone switches fuel preference to lipids in promoting thermogenesis under cold exposure in C57BL/6 mice.
    Gao R; Chen W; Yan H; Xie X; Liu D; Wu C; Zhu Z; Li H; Dong F; Wang L
    J Proteomics; 2018 Mar; 176():24-36. PubMed ID: 29414316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
    Takasawa K; Kubota N; Terauchi Y; Kadowaki T
    Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
    Lu M; Sarruf DA; Talukdar S; Sharma S; Li P; Bandyopadhyay G; Nalbandian S; Fan W; Gayen JR; Mahata SK; Webster NJ; Schwartz MW; Olefsky JM
    Nat Med; 2011 May; 17(5):618-22. PubMed ID: 21532596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
    Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.
    Lecka-Czernik B; Ackert-Bicknell C; Adamo ML; Marmolejos V; Churchill GA; Shockley KR; Reid IR; Grey A; Rosen CJ
    Endocrinology; 2007 Feb; 148(2):903-11. PubMed ID: 17122083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
    Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL
    J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
    Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
    Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis.
    Kim HL; Park J; Jung Y; Ahn KS; Um JY
    Phytomedicine; 2019 Jan; 52():254-263. PubMed ID: 30599906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA; Cvoro A; Amato AA; Sieglaff DH; Filgueira CS; Arumanayagam AS; de Lima Mdo C; Pitta IR; de Assis Rocha Neves F; Webb P
    Biochem Biophys Res Commun; 2015 Aug; 464(3):718-23. PubMed ID: 26168725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages.
    Nguyen MT; Chen A; Lu WJ; Fan W; Li PP; Oh DY; Patsouris D
    PLoS One; 2012; 7(4):e34976. PubMed ID: 22529965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering PPARgamma ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers.
    Samarasinghe SP; Sutanto MM; Danos AM; Johnson DN; Brady MJ; Cohen RN
    Obesity (Silver Spring); 2009 May; 17(5):965-72. PubMed ID: 19165156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.